Image de couverture de livre

Designing an exploratory phase 2b platform trial in NASH with correlated, co-primary binary endpoints

Fuente: arXiv

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Meyer, Elias Laurin, Mesenbrink, Peter, Di Prospero, Nicholas A., Pericàs, Juan M., Glimm, Ekkehard, Ratziu, Vlad, Sena, Elena, König, Franz
Format:	Preprint
Publié:	2022
Sujets:	Applications
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Exact matching as an alternative to propensity score matching
par: Glimm, Ekkehard, et autres
Publié: (2025)

A novel longitudinal rank-sum test for multiple primary endpoints in clinical trials: Applications to neurodegenerative disorders
par: Xu, Xiaoming, et autres
Publié: (2024)

Futility Analysis under Scrutiny
par: Jin, Rui, et autres
Publié: (2025)

Optimal allocation strategies in platform trials
par: Roig, Marta Bofill, et autres
Publié: (2023)

Rank-based estimators of global treatment effects for cluster randomized trials with multiple endpoints
par: Smith, E. Davies, et autres
Publié: (2024)

Evaluating amyloid-beta as a surrogate endpoint in trials of anti-amyloid drugs in Alzheimer's disease: a Bayesian meta-analysis
par: Ren, Sa, et autres
Publié: (2025)

A comparison of methods for designing hybrid type 2 cluster-randomized trials with continuous effectiveness and implementation endpoints
par: Owen, Melody, et autres
Publié: (2025)

While-alive regression analysis of composite survival endpoints
par: Fang, Xi, et autres
Publié: (2025)

NCC: An R-package for analysis and simulation of platform trials with non-concurrent controls
par: Krotka, Pavla, et autres
Publié: (2023)

Using shrinkage methods to estimate treatment effects in overlapping subgroups in randomized clinical trials with a time-to-event endpoint
par: Wolbers, Marcel, et autres
Publié: (2024)

Prediction intervals for overdispersed binomial endpoints and their application to toxicological historical control data
par: Menssen, Max, et autres
Publié: (2024)

Visualizing the treatment effect on kidney hierarchical composite endpoints: From mosaic to maraca plots
par: Karpefors, Martin, et autres
Publié: (2025)

Microbial correlation: a semi-parametric model for investigating microbial co-metabolism
par: Shi, Haoran, et autres
Publié: (2025)

Optimal allocation of trials to sub-regions in crop variety testing with multiple years and correlated genotype effects
par: Prus, Maryna, et autres
Publié: (2026)

Use of surrogate endpoints in health technology assessment: a review of selected NICE technology appraisals in oncology
par: Wheaton, Lorna, et autres
Publié: (2024)

Nonparametric estimation of an optimal treatment rule with fused randomized trials and missing effect modifiers
par: Williams, Nicholas, et autres
Publié: (2025)

Assessing treatment efficacy for interval-censored endpoints using multistate semi-Markov models fit to multiple data streams
par: Morsomme, Raphael, et autres
Publié: (2025)

The role of randomization inference in unraveling individual treatment effects in early phase vaccine trials
par: Chen, Zhe, et autres
Publié: (2023)

Cristiano Ronaldo or Lionel Messi, who is more consistent in scoring goals? The evidence from CFM exploratory analysis
par: Anwar, Samsul, et autres
Publié: (2026)

A response-adaptive multi-arm design for continuous endpoints based on a weighted information measure
par: Caruso, Gianmarco, et autres
Publié: (2024)

Scaling behavioral incentives for low-carbon mobility through digital platforms
par: Liu, Bing, et autres
Publié: (2025)

Shared Keyboard: An improved Bayesian design for phase I clinical trials via Beta kernel process
par: Zhao, Jiangyan, et autres
Publié: (2026)

Mosqlimate: a platform to providing automatable access to data and forecasting models for arbovirus disease
par: Ganem, Fabiana, et autres
Publié: (2024)

Equipoise calibration of clinical trial design
par: Rigat, Fabio
Publié: (2025)

Uncovering migration systems through spatio-temporal tensor co-clustering
par: Almquist, Zack W., et autres
Publié: (2021)

Early developmental carry‐over effects on exploratory behaviour and DNA methylation in wild great tits (Parus major)
par: Bernice Sepers, et autres
Publié: (2024)

Model-based indicators for co-clustered environments and species communities
par: Scherting, Braden, et autres
Publié: (2025)

Shotgun DNA sequencing evidence: sample-specific and unknown genotyping error probabilities
par: Andersen, Mikkel Meyer
Publié: (2025)

On misconceptions about the Brier score in binary prediction models
par: Hoessly, Linard
Publié: (2025)

Evaluation of clinical utility in emulated clinical trials
par: Hruza, Johannes, et autres
Publié: (2025)

Incorporating estimands into meta-analyses of clinical trials
par: Remiro-Azócar, Antonio, et autres
Publié: (2025)

tsbootstrap: Enhancing Time Series Analysis with Advanced Bootstrapping Techniques
par: Gilda, Sankalp, et autres
Publié: (2024)

Yield forecasting based on short time series with high spatial resolution data
par: Pokal, Sayli, et autres
Publié: (2024)

The Bayesian optimal two-stage design for clinical phase II trials based on Bayes factors
par: Kelter, Riko, et autres
Publié: (2025)

Monitoring overall survival in pivotal trials in indolent cancers
par: Fleming, Thomas R, et autres
Publié: (2023)

Benchmarking covariate-adjustment strategies for randomized clinical trials
par: Shao, Yulin, et autres
Publié: (2026)

Mixed additive modelling of global alien species co-invasions of plants and insects
par: Boschi, Martina, et autres
Publié: (2023)

Generalizing conditional average treatment effects from nested randomized trials to all trial-eligible individuals
par: Wen, Lan, et autres
Publié: (2026)

Negative correlations in Ising models of credit risk
par: Emonti, Chiara, et autres
Publié: (2025)

Clinical trials with interim analyses: Standardizing Terminology to increase clarity
par: Asikanius, Elina, et autres
Publié: (2024)